| Literature DB >> 26212412 |
Kenya Yamamoto1, Mitsuhiro Kudo, Heihachiro Arito, Yasutaka Ogawa, Tsutomu Takata.
Abstract
This cross-sectional study was intended to examine health effects of 678 male workers employed during an 8-yr period from 2000 to 2007 at 36 municipal and private waste incineration plants in Japan. Blood samples were obtained for analysis of concentrations of dioxins including coplanar polychlorinated biphenyls (coplanar PCBs) and evaluation of health effects. Health effects including diabetes were surveyed via a physician's interview or clinical data from blood samples. There was a certain difference in serum concentrations of polychlorinated dibenzofurans (PCDFs) between the incinerator workers and Japanese general population, although no differences in the concentrations of total dioxins or polychlorinated dibenzo-p-dioxins (PCDDs) were found between the two groups. A few positive correlations between serum levels of PCDDs and PCDFs and the results of laboratory and physiological tests were found, but coplanar PCBs showed significant relations with 14 parameters of the tests. The background serum levels of PCDDs, PCDFs and total dioxins were significantly associated with the prevalence of diabetes. No essential differences in serum concentrations of total dioxins and in prevalence of diabetes between our subjects and the general population suggested that the incinerator workers were marginally exposed to dioxins in the workplace without any recognizable adverse health effects.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26212412 PMCID: PMC4591139 DOI: 10.2486/indhealth.2015-0006
Source DB: PubMed Journal: Ind Health ISSN: 0019-8366 Impact factor: 2.179
Demographic characteristics of the study population
| Number of plants | 36 | |||
| Number of subjects | 678 | |||
| Working duration (yr)1 | 12.4 ± 9.4 | |||
| Age (yr)1 | 43.1 ± 11.1 | |||
| Percent body fat (%)1 | 22.9 ± 61 | |||
| Body mass index1 | 24.0 ± 3.3 | |||
| Smoking habit | n | Ratio | ||
| Nonsmoker | 121 | 17.8% | ||
| Smoker | 556 | 82.0% | ||
| Ex-smoker | 165 | 24.3% | ||
| Current smoker | 390 | 57.5% | ||
| Unknown | 1 | 0.1% | ||
| Alcohol consumption | n | Ratio | ||
| Nondrinker | 126 | 18.6% | ||
| Drinker | 551 | 81.3% | ||
| 2–3 times/month | 96 | 14.2% | ||
| 2–3 times/wk | 220 | 32.4% | ||
| Everyday | 225 | 33.2% | ||
| Unknown | 10 | 1.5% | ||
| Job categories2 | n | Ratio | ||
| I | 39 | 5.8% | ||
| II | 11 | 1.6% | ||
| III | 70 | 10.3% | ||
| IV | 550 | 81.1% | ||
| Unknown | 8 | 1.2% | ||
| Personal protective equipment | n | Rate | ||
| Respirators | 625 | 92.2% | ||
| Goggles | 413 | 60.9% | ||
| Gloves | 480 | 70.8% | ||
| Number of diseases | n | Rate | ||
| Hypertension | 304 | 44.8% | ||
| Diabetes mellitus | 45 | 6.6% | ||
| Hyperlipidemia | 362 | 53.4% | ||
| Liver dysfunction | 211 | 31.1% | ||
1The values represent arithmetic means ± SD. 2Job categories I to IV are described in Subjects and Methods.
Number of diseases and characteristics of the subjects according to quartiles of serum concentrations of dioxin congeners
| Cut-off value | n | Working duration | Age (yr) | Percent body fat | BMI | Smoking habit | Alcohol consumption | Number of diseases2 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Smoker | Drinker | HTN | DM | HL | LDF | ||||||||
| Total Dioxins | |||||||||||||
| Q11 | <9.76 | 169 | 9.23 ± 7.7 | 35.3 ± 10.5 | 21.6 ± 6.5 | 23.0 ± 3.4 | 143 | 123 | 50 | 3 | 65 | 35 | |
| Q2 | ≥9.76 | 170 | 12.2 ± 9.4 | 41.8 ± 10.3 | 23.8 ± 5.8 | 24.6 ± 3.6 | 141 | 138 | 66 | 4 | 94 | 50 | |
| Q3 | ≥13.70 | 170 | 12.7± 9.2 | 46.7 ± 8.9 | 23.1 ± 5.5 | 24.3 ± 3.1 | 132 | 145 | 90 | 16 | 105 | 66 | |
| Q4 | ≥21.67 | 169 | 15.5 ± 10.0 | 48.7 ± 9.7 | 22.8 ± 4.8 | 24.2 ± 2.8 | 140 | 145 | 98 | 22 | 98 | 60 | |
| PCDDs | |||||||||||||
| Q1 | <4.34 | 169 | 9.4 ± 7.9 | 36.6 ± 11.1 | 22.1 ± 6.7 | 23.2 ± 3.5 | 136 | 126 | 54 | 3 | 65 | 35 | |
| Q2 | ≥4.34 | 170 | 11.8 ± 8.9 | 42.0 ± 10.4 | 23.0 ± 5.3 | 24.1 ± 3.5 | 148 | 136 | 76 | 7 | 98 | 54 | |
| Q3 | ≥6.09 | 170 | 13.5 ± 9.7 | 45.8 ± 9.5 | 23.6 ± 5.2 | 24.5 ± 3.1 | 135 | 146 | 80 | 10 | 103 | 63 | |
| Q4 | ≥8.98 | 169 | 15.1 ± 9.9 | 48.0 ± 10.0 | 22.6 ± 5.2 | 24.3 ± 3.6 | 137 | 143 | 94 | 25 | 96 | 59 | |
| PCDFs | |||||||||||||
| Q1 | <2.16 | 169 | 10.1 ± 8.3 | 36.2 ± 10.1 | 22.9 ± 6.7 | 23.4 ± 3.6 | 136 | 126 | 52 | 3 | 69 | 47 | |
| Q2 | ≥2.16 | 170 | 11.6 ± 9.0 | 42.8 ± 10.3 | 22.8 ± 5.8 | 24.3 ± 3.1 | 151 | 143 | 73 | 5 | 99 | 50 | |
| Q3 | ≥3.10 | 170 | 13.4 ± 9.9 | 45.2 ± 10.2 | 23.2 ± 5.9 | 24.2 ± 3.1 | 134 | 141 | 87 | 15 | 105 | 57 | |
| Q4 | ≥4.51 | 169 | 14.6 ± 9.6 | 48.1 ± 10.2 | 22.4 ± 4.5 | 24.2 ± 2.8 | 135 | 141 | 92 | 22 | 89 | 57 | |
| Coplanar PCBs | |||||||||||||
| Q1 | <2.60 | 169 | 9.3 ± 7.6 | 34.3 ± 10.0 | 21.7 ± 6.5 | 23.2 ± 3.5 | 144 | 119 | 46 | 2 | 68 | 2 | |
| Q2 | ≥2.60 | 170 | 12.2 ± 9.5 | 42.4 ± 10.0 | 23.3 ± 5.7 | 24.1 ± 3.3 | 144 | 142 | 69 | 9 | 91 | 53 | |
| Q3 | ≥4.45 | 169 | 12.3 ± 8.9 | 45.6 ± 9.3 | 23.3 ± 5.4 | 24.3 ± 3.2 | 127 | 139 | 84 | 14 | 97 | 63 | |
| Q4 | ≥7.30 | 170 | 15.9 ± 10.1 | 50.0 ± 8.7 | 23.0 ± 5.2 | 24.4 ± 3.0 | 141 | 151 | 105 | 20 | 106 | 66 | |
1Q1, Q2, Q3 and Q4 stand for the 1st, 2nd, 3rd and 4th quartiles, respectively. 2HTN: hypertension; DM: diabetes mellitus; HL: hyperlipidemia; LDF: liver dysfunction
Distribution of serum concentrations of dioxin isomers in Japanese incinerator workers
| Dioxins | TEF | Median | Min | Max | |
|---|---|---|---|---|---|
| (pg TEQ/g lipid) | |||||
| PCDDs | 6.08 | 1.88 | 54.27 | ||
| 2,3,7,8-TCDD | 1 | 0.50 | 0.50 | 6.10 | |
| 1,2,3,7,8-PeCDD | 1 | 3.40 | 0.50 | 35.40 | |
| 1,2,3,4,7,8-HxCDD | 0.1 | 0.10 | 0.05 | 2.90 | |
| 1,2,3,6,7,8-HxCDD | 0.1 | 1.48 | 0.27 | 11.75 | |
| 1,2,3,7,8,9-HxCDD | 0.1 | 0.24 | 0.10 | 3.38 | |
| 1,2,3,4,6,7,8-HpCDD | 0.01 | 0.09 | 0.00 | 2.00 | |
| OCDD | 0.0003 | 0.03 | 0.00 | 3.30 | |
| PCDFs | 3.10 | 0.85 | 57.36 | ||
| 2,3,7,8-TCDF | 0.1 | 0.05 | 0.05 | 0.62 | |
| 1,2,3,7,8-PeCDF | 0.03 | 0.02 | 0.00 | 0.19 | |
| 2,3,4,7,8-PeCDF | 0.3 | 2.10 | 0.36 | 27.24 | |
| 1,2,3,4,7,8-HxCDF | 0.1 | 0.25 | 0.10 | 7.63 | |
| 1,2,3,6,7,8-HxCDF | 0.1 | 0.34 | 0.10 | 13.29 | |
| 1,2,3,7,8,9-HxCDF | 0.1 | 0.10 | 0.10 | 1.04 | |
| 2,3,4,6,7,8-HxCDF | 0.1 | 0.10 | 0.10 | 6.84 | |
| 1,2,3,4,6,7,8-HpCDF | 0.01 | 0.03 | 0.00 | 3.13 | |
| 1,2,3,4,7,8,9-HpCDF | 0.01 | 0.01 | 0.00 | 0.33 | |
| OCDF | 0.0003 | 0.00 | 0.00 | 0.01 | |
| Coplanar PCBs | 4.45 | 0.72 | 36.41 | ||
| Non-ortho PCBs | |||||
| PCB77 | 0.0001 | 0.00 | 0.00 | 0.02 | |
| PCB81 | 0.0003 | 0.00 | 0.00 | 0.01 | |
| PCB126 | 0.1 | 3.00 | 0.50 | 31.13 | |
| PCB169 | 0.03 | 0.84 | 0.15 | 7.38 | |
| Mono-ortho PCBs | |||||
| PCB105 | 0.00003 | 0.03 | 0.00 | 0.30 | |
| PCB114 | 0.00003 | 0.01 | 0.00 | 0.08 | |
| PCB118 | 0.00003 | 0.17 | 0.00 | 1.26 | |
| PCB123 | 0.00003 | 0.00 | 0.00 | 0.02 | |
| PCB156 | 0.00003 | 0.09 | 0.00 | 0.76 | |
| PCB157 | 0.00003 | 0.02 | 0.00 | 0.15 | |
| PCB167 | 0.00003 | 0.03 | 0.00 | 0.19 | |
| PCB189 | 0.00003 | 0.01 | 0.00 | 0.11 | |
| Total dioxins | 13.70 | 3.74 | 110.32 | ||
Arithmetic means of serum concentrations of dioxin isomers (pg TEQ/g lipid) for each age group of incinerator workers compared with the reference data obtained from the MOEJ report27)
| Dioxins | This study | Japanese general population1 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age (yr old) | Ratio2 | Age (yr old) | Ratio2 | ||||||||||||||
| 20–29 | 30–39 | 40–49 | 50–59 | >60 | Total | 20–29 | 30–39 | 40–49 | 50–59 | >60 | Total | ||||||
| PCDDs | 4.29 | 6.07 | 8.07 | 9.20 | 8.86 | 7.35 | 42.6% | 5.04 | 5.60 | 7.48 | 10.62 | 12.01 | 8.10 | 41.8% | |||
| 2,3,7,8-TCDD | 0.66 | 0.76 | 0.95 | 1.14 | 1.13 | 0.93 | 5.4% | 0.42 | 0.52 | 0.69 | 1.38 | 1.56 | 0.91 | 4.7% | |||
| 1,2,3,7,8-PeCDD | 2.45 | 3.26 | 4.48 | 4.84 | 4.79 | 4.02 | 23.3% | 3.18 | 3.43 | 4.55 | 6.43 | 7.35 | 4.96 | 25.6% | |||
| 1,2,3,4,7,8-HxCDD | 0.12 | 0.16 | 0.20 | 0.19 | 0.18 | 0.18 | 1.0% | 0.05 | 0.06 | 0.11 | 0.19 | 0.23 | 0.13 | 0.6% | ** | ||
| 1,2,3,6,7,8-HxCDD | 1.01 | 1.56 | 1.87 | 2.15 | 1.94 | 1.75 | 10.2% | 1.08 | 1.26 | 1.66 | 2.00 | 2.17 | 1.63 | 8.4% | * | ||
| 1,2,3,7,8,9-HxCDD | 0.17 | 0.26 | 0.34 | 0.37 | 0.30 | 0.30 | 1.8% | 0.16 | 0.18 | 0.26 | 0.35 | 0.39 | 0.27 | 1.4% | * | ||
| 1,2,3,4,6,7,8-HpCDD | 0.09 | 0.12 | 0.12 | 0.14 | 0.11 | 0.12 | 0.7% | 0.11 | 0.11 | 0.14 | 0.18 | 0.19 | 0.15 | 0.8% | |||
| OCDD | 0.03 | 0.04 | 0.05 | 0.08 | 0.05 | 0.05 | 0.3% | 0.03 | 0.04 | 0.06 | 0.09 | 0.10 | 0.07 | 0.3% | |||
| PCDFs | 2.24 | 3.30 | 4.79 | 4.87 | 5.50 | 4.12 | 23.9% | 2.14 | 2.21 | 3.00 | 4.44 | 5.44 | 3.40 | 17.6% | ** | ||
| 2,3,7,8-TCDF | 0.06 | 0.07 | 0.08 | 0.09 | 0.10 | 0.08 | 0.4% | 0.06 | 0.06 | 0.09 | 0.12 | 0.13 | 0.09 | 0.5% | |||
| 1,2,3,7,8-PeCDF | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.1% | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.01 | 0.0% | ** | ||
| 2,3,4,7,8-PeCDF | 1.52 | 2.02 | 2.99 | 3.20 | 3.59 | 2.64 | 15.3% | 1.51 | 1.68 | 2.29 | 3.40 | 4.24 | 2.59 | 13.4% | |||
| 1,2,3,4,7,8-HxCDF | 0.24 | 0.31 | 0.45 | 0.37 | 0.39 | 0.36 | 2.1% | 0.21 | 0.15 | 0.22 | 0.32 | 0.38 | 0.25 | 1.3% | ** | ||
| 1,2,3,6,7,8-HxCDF | 0.30 | 0.48 | 0.70 | 0.56 | 0.63 | 0.55 | 3.2% | 0.25 | 0.24 | 0.31 | 0.44 | 0.51 | 0.34 | 1.8% | ** | ||
| 1,2,3,7,8,9-HxCDF | 0.12 | 0.11 | 0.11 | 0.11 | 0.12 | 0.11 | 0.6% | 0.03 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.0% | † | ||
| 2,3,4,6,7,8-HxCDF | 0.13 | 0.25 | 0.32 | 0.26 | 0.31 | 0.26 | 1.5% | 0.04 | 0.05 | 0.07 | 0.13 | 0.15 | 0.09 | 0.4% | ** | ||
| 1,2,3,4,6,7,8-HpCDF | 0.06 | 0.08 | 0.12 | 0.08 | 0.08 | 0.09 | 0.5% | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.1% | ** | ||
| 1,2,3,4,7,8,9-HpCDF | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.1% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0% | † | ||
| OCDF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0% | † | ||
| Coplanar PCBs | 2.23 | 3.79 | 6.01 | 8.28 | 9.12 | 5.76 | 33.4% | 3.40 | 4.39 | 6.78 | 11.12 | 14.03 | 7.85 | 40.6% | |||
| Non-ortho PCBs | |||||||||||||||||
| PCB77 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0% | † | ||
| PCB81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0% | † | ||
| PCB126 | 1.70 | 2.86 | 4.40 | 5.90 | 6.33 | 4.17 | 24.2% | 2.56 | 3.32 | 5.15 | 8.63 | 10.86 | 6.03 | 31.2% | |||
| PCB169 | 0.59 | 0.76 | 1.05 | 1.33 | 1.56 | 1.02 | 5.9% | 0.60 | 0.75 | 1.11 | 1.66 | 2.07 | 1.23 | 6.3% | |||
| Mono-ortho PCBs | |||||||||||||||||
| PCB105 | 0.02 | 0.03 | 0.05 | 0.07 | 0.07 | 0.05 | 0.3% | 0.02 | 0.03 | 0.05 | 0.08 | 0.10 | 0.06 | 0.3% | |||
| PCB114 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.1% | 0.01 | 0.01 | 0.02 | 0.03 | 0.04 | 0.02 | 0.1% | |||
| PCB118 | 0.10 | 0.16 | 0.24 | 0.33 | 0.37 | 0.23 | 1.4% | 0.13 | 0.17 | 0.27 | 0.43 | 0.57 | 0.31 | 1.6% | |||
| PCB123 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0% | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.0% | † | ||
| PCB156 | 0.05 | 0.06 | 0.11 | 0.14 | 0.17 | 0.10 | 0.6% | 0.04 | 0.06 | 0.10 | 0.16 | 0.21 | 0.11 | 0.6% | |||
| PCB157 | 0.01 | 0.02 | 0.03 | 0.03 | 0.04 | 0.02 | 0.1% | 0.01 | 0.02 | 0.03 | 0.04 | 0.06 | 0.03 | 0.2% | |||
| PCB167 | 0.01 | 0.02 | 0.04 | 0.05 | 0.06 | 0.03 | 0.2% | 0.02 | 0.03 | 0.04 | 0.07 | 0.10 | 0.05 | 0.3% | |||
| PCB189 | 0.06 | 0.07 | 0.12 | 0.15 | 0.18 | 0.01 | 0.1% | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.1% | |||
| Total dioxins | 8.77 | 13.16 | 18.86 | 22.35 | 23.49 | 17.23 | 100.0% | 10.58 | 12.19 | 17.25 | 26.18 | 31.47 | 19.35 | 100.0% | |||
1Serum concentrations of dioxins in the male and female general population living in all areas of Japan obtained from the MOEJ report27). 2Isomer ratios indicate the ratios of dioxin isomers to total dioxins in both this study and the MOEJ report. 3p was computed using the paired t-test for comparison of arithmetic means between this study and the MOEJ survey (*p<0.05, **p<0.01). †The t-test was not applied because the arithmetic mean value in the MOEJ survey was zero.
Fig. 1.Scatterplots of the serum concentrations of dioxins and job duration for each job category in the Japanese waste incinerator workers. Job categories I, II, III and IV are indicated by a closed circle (●), open circle (○), triangle (▽) and cross (×), respectively.
Correlations between serum concentrations of dioxin congeners and parameters of laboratory and physiological tests in the subjects working for waste incineration facilities
| Median | Min | Max | Pearson’s correlation coefficient | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PCDDs | PCDFs | Coplanar PCBs | Total dioxins | |||||||||
| Physiological test | ||||||||||||
| SBP (mmHg) | 133 | 74 | 233 | –0.0097 | 0.0118 | 0.0985 | * | 0.0375 | ||||
| DBP (mmHg) | 81 | 40 | 127 | 0.0488 | 0.0695 | 0.1435 | ** | 0.0961 | * | |||
| Heart rate (count/min) | 75 | 48 | 135 | 0.0324 | –0.0347 | 0.0570 | 0.0251 | |||||
| Blood cell count | ||||||||||||
| WBC (count/μl) | 6,800 | 3,220 | 14,100 | 0.0306 | –0.0049 | –0.0646 | –0.0143 | |||||
| RBC (×104 count/μl) | 483 | 357 | 629 | 0.0077 | –0.0309 | 0.0110 | –0.0061 | |||||
| Hb (g/dl) | 15.3 | 11.9 | 19.8 | 0.0256 | –0.0130 | 0.0725 | 0.0360 | |||||
| HT (%) | 44.8 | 31.7 | 58.8 | 0.0093 | –0.0256 | 0.0276 | 0.0058 | |||||
| PLT (×104 count/μl) | 23.8 | 3.8 | 43.8 | –0.0593 | –0.0951 | –0.1067 | ** | –0.0946 | * | |||
| Blood chemistry test | ||||||||||||
| TP (g/dl) | 7.2 | 5.9 | 9.2 | 0.0613 | 0.0932 | * | 0.1024 | ** | 0.0864 | * | ||
| Alb (g/dl) | 4.7 | 3.8 | 5.8 | 0.0233 | 0.0802 | * | 0.1002 | ** | 0.0686 | |||
| T-bil (mg/dl) | 0.6 | 0.2 | 5.1 | –0.0246 | 0.0439 | 0.0909 | * | 0.0402 | ||||
| AST (IU/l) | 23 | 11 | 131 | 0.0262 | 0.0168 | 0.1610 | ** | 0.0818 | ||||
| ALT (IU/l) | 25 | 6 | 224 | 0.0331 | –0.0100 | 0.1507 | ** | 0.0663 | ||||
| LDH (IU/l)1 | 216 | 96 | 1,174 | 0.0080 | 0.0176 | 0.0461 | 0.0188 | |||||
| LDH (IU/l)2 | 170 | 119 | 363 | –0.0673 | –0.0098 | –0.0706 | –0.0633 | |||||
| ALP (IU/l) | 219 | 83 | 730 | –0.0523 | –0.0680 | –0.0373 | –0.0595 | |||||
| LAP (IU/l) | 55 | 23 | 192 | 0.0313 | –0.0090 | 0.1193 | ** | 0.0585 | ||||
| GGT (IU/l) | 38 | 10 | 1,133 | 0.0530 | 0.0060 | 0.1946 | ** | 0.1033 | ** | |||
| AMY (IU/l) | 70 | 25 | 231 | –0.0503 | –0.0746 | –0.0817 | * | –0.0777 | * | |||
| CK (IU/l) | 119 | 35 | 3,087 | 0.0508 | 0.0703 | 0.0428 | 0.0598 | |||||
| Fe (μg/dl) | 101 | 21 | 277 | 0.0314 | 0.0506 | 0.0922 | * | 0.0608 | ||||
| BUN (mg/dl) | 13 | 6 | 24 | 0.0227 | 0.0506 | 0.0881 | * | 0.0579 | ||||
| UA (mg/dl) | 5.7 | 2.7 | 10.7 | 0.0250 | –0.0263 | 0.0884 | * | 0.0336 | ||||
| Cr (mg/dl) | 0.8 | 0.4 | 1.5 | –0.0530 | –0.0209 | –0.0863 | * | –0.0629 | ||||
| T-ch (mg/dl) | 199 | 99 | 385 | 0.0329 | –0.0232 | 0.0517 | 0.0166 | |||||
| HDL-ch (mg/dl) | 53 | 17 | 131 | –0.0184 | 0.0090 | 0.0197 | 0.0006 | |||||
| TG (mg/dl) | 121 | 31 | 2363 | 0.0155 | –0.0523 | 0.0998 | * | 0.0317 | ||||
| BS (mg/dl) | 95 | 63 | 446 | 0.0440 | –0.0306 | 0.1042 | ** | 0.0559 | ||||
| HbA1c (%) | 4.8 | 2.1 | 11.8 | 0.0917 | * | 0.0961 | * | 0.0525 | 0.0906 | |||
| Immunological function test | ||||||||||||
| PHA (cpm) | 38,774 | 2,275 | 60907 | –0.0791 | * | –0.1121 | ** | –0.0102 | –0.0702 | |||
| ConA (cpm) | 32,095 | 1,595 | 64,400 | –0.0148 | 0.0064 | 0.0091 | –0.0027 | |||||
| PHA-SI3 | 122.2 | 4.0 | 606.2 | –0.0279 | –0.1140 | ** | 0.0208 | –0.0330 | ||||
| ConA-SI4 | 99.5 | 2.8 | 334.8 | 0.0028 | –0.0542 | –0.0320 | 0.0007 | |||||
| NKACT (%) | 38.0 | 5.0 | 79.0 | –0.0062 | 0.0269 | 0.0416 | 0.0238 | |||||
| CD3 (%) | 72.6 | 43.1 | 89.2 | –0.0407 | –0.0344 | –0.0509 | –0.0510 | |||||
| CD4 (%) | 45.2 | 14.9 | 74.6 | –0.0202 | –0.0569 | –0.0449 | –0.0405 | |||||
| CD8 (%) | 29.3 | 10.5 | 60.8 | 0.0146 | 0.0661 | 0.0295 | 0.0339 | |||||
| CD4/CD8 ratio | 1.6 | 0.3 | 5.6 | –0.0190 | –0.0699 | –0.0406 | –0.0413 | |||||
| CD19 (%) | 8.6 | 0.5 | 25.9 | 0.0417 | 0.0421 | –0.0380 | 0.0121 | |||||
| CD56 (%) | 16.1 | 3.1 | 48.7 | –0.0183 | 0.0369 | 0.0600 | 0.0448 | |||||
Adjusted for age, survey year, BMI, smoking habits and alcohol consumption. *p<0.05, **p<0.01. 1,2The LDH data measured at Rousai Hospitals were adjusted as described in Subjects and Methods. 3,4SI indicates the Stimulation Index. SBP: Systolic blood pressure; DBP: Diastolic blood pressure; WBC: White blood cell; RBC: Red blood cell; Hb: Hemoglobin; Ht: Hematocrit; PLT: Platelet; TP: Total protein; Al: Albumin; T-bil: Total bilirubin; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; LDH: Lactate dehydrogenase; ALP: Alkaline phosphatase; LAP: Leucine aminopeptidase; GGT: Gamma-glutamyltransferase; AMY: Amylase; CK: Creatine kinase; Fe: Ferrum (iron); BUN: Blood urea nitrogen; UA: Urinary acid; Cr: Creatinine; T-cho: Total cholesterol; HDL-ch: High-density lipoprotein cholesterol; TG: Triglyceride; BS: Blood sugar; HbA1c: Hemoglobin-A1c; PHA: Lymphocyte blastoid transformation by Phytohemaggutinin; ConA: Lymphocyte blastoid transformation by Concanavalin A; NKACT: Natural killer cell activity; CD: Cluster of differentiation
Significant partial regression coefficients computed using multiple regression analysis
| Laboratory or physiological test | Total dioxins | |||
| B | 95% CIs | |||
| Lower | Upper | |||
| PLT (×104 count/µl) | –0.002 | –0.003 | 0.000 | <0.05 |
| Laboratory or physiological test | PCDFs | |||
| B | 95% CIs | |||
| Lower | Upper | |||
| GGT (IU/l) | –0.012 | –0.023 | 0.000 | <0.05 |
| T-ch (mg/dl) | –0.003 | –0.006 | 0.000 | <0.05 |
| Laboratory or physiological test | Coplanar PCBs | |||
| B | 95% CIs | |||
| Lower | Upper | |||
| SBP (mmHg) | 0.003 | 0.001 | 0.006 | <0.01 |
| DBP (mmHg) | 0.004 | 0.001 | 0.006 | <0.01 |
| Hb (g/dl) | 0.001 | 0.000 | 0.003 | <0.05 |
| PLT (×104 count/µl) | –0.005 | –0.009 | –0.001 | <0.05 |
| TP (g/dl) | 0.001 | 0.000 | 0.002 | <0.05 |
| AST (IU/l) | 0.013 | 0.006 | 0.019 | <0.01 |
| ALT (IU/l) | 0.014 | 0.005 | 0.023 | <0.01 |
| LAP (IU/l) | 0.006 | 0.002 | 0.009 | <0.01 |
| GGT (IU/l) | 0.026 | 0.014 | 0.039 | <0.01 |
| BUN (mg/dl) | 0.005 | 0.001 | 0.009 | <0.05 |
| TG (mg/dl) | 0.015 | 0.005 | 0.025 | <0.01 |
| BS (mg/dl) | 0.006 | 0.002 | 0.010 | <0.01 |
| HbA1c (%) | 0.002 | 0.000 | 0.004 | <0.05 |
| CD3 (%) | –0.003 | –0.005 | 0.000 | <0.05 |
B: partial regression coefficient; CIs: confidence intervals. Adjusted for age, survey year, BMI, smoking habit and alcohol consumption.
p was computed using the Wald test.
Adjusted odds ratios (ORs) and 95% confidence intervals (95% CIs) of the quartiles of serum concentrations of dioxin congeners to prevalence of diabetes mellitus and hypertension
| Diabetes mellitus | Hypertension | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ORs | 95% CIs | ORs | 95% CIs | |||||||
| Lower | Upper | Lower | Upper | |||||||
| PCDDs | ||||||||||
| Q1: | 1.00 | 1.00 | ||||||||
| Q2: | 2.33 | 0.50 | 10.86 | 0.28 | 1.35 | 0.84 | 2.19 | 0.22 | ||
| Q3: | 3.18 | 0.71 | 14.23 | 0.13 | 1.16 | 0.71 | 1.91 | 0.55 | ||
| Q4: | 6.70 | 1.61 | 27.91 | <0.01 | 1.66 | 1.00 | 2.78 | 0.05 | ||
| <0.05 | <0.05 | |||||||||
| PCDFs | ||||||||||
| Q1: | 1.00 | 1.00 | ||||||||
| Q2: | 1.56 | 0.31 | 7.77 | 0.59 | 1.34 | 0.82 | 2.19 | 0.24 | ||
| Q3: | 4.20 | 0.99 | 17.81 | 0.05 | 1.74 | 1.06 | 2.87 | <0.05 | ||
| Q4: | 5.69 | 1.32 | 24.53 | <0.05 | 1.90 | 1.12 | 3.25 | <0.05 | ||
| <0.05 | <0.05 | |||||||||
| Coplanar PCBs | ||||||||||
| Q1: | 1.00 | 1.00 | ||||||||
| Q2: | 3.30 | 0.60 | 18.04 | 0.17 | 1.26 | 0.76 | 2.09 | 0.37 | ||
| Q3: | 4.84 | 0.91 | 25.68 | 0.06 | 1.66 | 0.99 | 2.79 | 0.05 | ||
| Q4: | 5.36 | 1.00 | 28.72 | 0.05 | 2.31 | 1.33 | 4.02 | <0.01 | ||
| <0.05 | <0.05 | |||||||||
| Total dioxins | ||||||||||
| Q1: | 1.00 | 1.00 | ||||||||
| Q2: | 1.28 | 0.24 | 6.85 | 0.77 | 1.01 | 0.62 | 1.66 | 0.96 | ||
| Q3: | 4.44 | 1.04 | 18.94 | <0.05 | 1.62 | 0.97 | 2.70 | 0.07 | ||
| Q4: | 4.98 | 1.17 | 21.17 | <0.05 | 1.92 | 1.12 | 3.28 | <0.05 | ||
| <0.05 | <0.05 | |||||||||
Adjusted for age, survey year, BMI, smoking habit and alcohol consumption. Q1, Q2, Q3 and Q4 stand for the 1st, 2nd, 3rd and 4th quartiles, respectively. p was computed using the Wald test. p for trend was computed using the Jonckheere trend test.
The prevalences of diabetes and hypertension in each age group of Japanese incinerator workers compared with those of the Japanese general population
| Age (yr) | Concentration of serum total dioxin (pg TEQ/g lipid) | Diabetes | Hypertension | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| This study | Japanese general population1 | This study | Japanese general population2 | This study | Japanese general population2 | |||||||||||||||
| Median | Min | Max | Median | Min | Max | n | Rate | n | Rate | Rate | n | Rate | ||||||||
| ≤29 | 8.3 | 3.9 | 32.6 | 11 | 0.8 | 54 | 98 | 1.0% | 114 | 0.0% | 0.28 | 23.5% | 122 | 6.6% | <0.01 | |||||
| 30–39 | 12.0 | 3.7 | 106.7 | 12 | 0.1 | 45 | 156 | 2.6% | 212 | 0.5% | 0.09 | 34.0% | 220 | 19.1% | <0.01 | |||||
| 40–49 | 14.4 | 5.3 | 100.0 | 17 | 1.5 | 95 | 201 | 5.5% | 207 | 4.8% | 0.05 | 46.3% | 214 | 35.5% | <0.05 | |||||
| 50–59 | 18.6 | 5.5 | 110.3 | 26 | 1.1 | 130 | 184 | 12.0% | 350 | 13.1% | 0.70 | 60.9% | 363 | 59.2% | 0.35 | |||||
| 60–69 | 21.3 | 7.2 | 110.2 | 31 | 6.9 | 120 | 39 | 17.9% | 389 | 14.7% | 0.58 | 59.0% | 411 | 66.7% | 0.33 | |||||
| Total | 13.7 | 3.7 | 110.3 | 19 | 0.1 | 130 | 678 | 6.6% | 1,272 | 9.0% | 0.07 | 44.8% | 1,330 | 46.2% | 0.55 | |||||
1Serum concentrations of dioxins in the male and female general population living in urban, farming and fishing areas of Japan obtained from the MOEJ reports27). 2The prevalences of diabetes and hypertension in the male Japanese general population were quoted from National Health and Nutrition Survey in 200632). p was computed with the χ2 test